Opus Capital Group, LLC Eli Lilly & CO Transaction History

Opus Capital Group, LLC

$800 Million
Q3 2024

A detailed history of Opus Capital Group, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Opus Capital Group, LLC holds 9,109 shares of LLY stock, worth $6.99 Million. This represents 1.01% of its overall portfolio holdings.

Number of Shares

9,109

Previous 1,103 725.84%

Holding current value

$6.99 Million

Previous $999,000 707.81%

% of portfolio

1.01%

Previous 0.14%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	BUY	$772.14 - $960.02 $6.18 Million - $7.69 Million	8,006 Added 725.84%	9,109 $8.07 Million
Q2 2024 Jul 31, 2024	SELL	$724.87 - $909.04 $12,322 - $15,453	-17 Reduced 1.52%	1,103 $999,000
Q1 2024 Apr 26, 2024	SELL	$592.2 - $792.28 $94,159 - $125,972	-159 Reduced 12.43%	1,120 $871,000
Q4 2023 Jan 31, 2024	SELL	$525.19 - $619.13 $6,302 - $7,429	-12 Reduced 0.93%	1,279 $746,000
Q3 2023 Oct 31, 2023	SELL	$434.7 - $599.3 $54,337 - $74,912	-125 Reduced 8.83%	1,291 $693,000
Q2 2023 Jul 31, 2023	BUY	$350.74 - $468.98 $6,664 - $8,910	19 Added 1.36%	1,416 $664,000
Q1 2023 Apr 24, 2023	SELL	$310.63 - $364.82 $7,455 - $8,755	-24 Reduced 1.69%	1,397 $480,000
Q4 2022 Jan 18, 2023	SELL	$321.55 - $374.67 $17,685 - $20,606	-55 Reduced 3.73%	1,421 $520,000
Q3 2022 Oct 31, 2022	SELL	$296.48 - $337.87 $2,964 - $3,378	-10 Reduced 0.67%	1,476 $477,000
Q2 2022 Jul 29, 2022	SELL	$278.73 - $327.27 $145,218 - $170,507	-521 Reduced 25.96%	1,486 $482,000
Q1 2022 Apr 25, 2022	SELL	$234.69 - $291.66 $704 - $874	-3 Reduced 0.15%	2,007 $575,000
Q4 2021 Jan 31, 2022	BUY	$224.85 - $279.04 $674 - $837	3 Added 0.15%	2,010 $555,000
Q3 2021 Oct 29, 2021	SELL	$221.6 - $272.71 $166,200 - $204,532	-750 Reduced 27.2%	2,007 $464,000
Q2 2021 Jul 29, 2021	SELL	$180.55 - $233.54 $38,457 - $49,744	-213 Reduced 7.17%	2,757 $633,000
Q1 2021 Apr 28, 2021	SELL	$164.32 - $212.72 $93,169 - $120,612	-567 Reduced 16.03%	2,970 $555,000
Q3 2020 Oct 30, 2020	SELL	$146.22 - $169.13 $82,614 - $95,558	-565 Reduced 13.77%	3,537 $524,000
Q2 2020 Jul 31, 2020	SELL	$136.42 - $164.18 $5,456 - $6,567	-40 Reduced 0.97%	4,102 $673,000
Q1 2020 Apr 30, 2020	SELL	$119.05 - $147.35 $40,357 - $49,951	-339 Reduced 7.57%	4,142 $575,000
Q4 2019 Jan 31, 2020	BUY	$106.92 - $132.43 $155,675 - $192,818	1,456 Added 48.13%	4,481 $589,000
Q2 2019 Aug 08, 2019	SELL	$110.79 - $129.32 $228,781 - $267,045	-2,065 Reduced 40.57%	3,025 $335,000
Q4 2018 Feb 07, 2019	BUY	$105.9 - $118.64 $539,031 - $603,877	5,090 New	5,090 $590,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $730B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Opus Capital Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Opus Capital Group, LLC with notifications on news.

Account

Opus Capital Group, LLC Eli Lilly & CO Transaction History